b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31148118</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>12</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>12</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1476-3524</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>36</Volume>\n                    <Issue>4</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Nov</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Neurotoxicity research</Title>\n                <ISOAbbreviation>Neurotox Res</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Increased Antiseizure Effectiveness with Tiagabine Combined with Sodium Channel Antagonists in Mice Exposed to Hyperbaric Oxygen.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>788-795</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12640-019-00063-5</ELocationID>\n            <Abstract>\n                <AbstractText>Hyperbaric oxygen (HBO<sub>2</sub>) is acutely toxic to the central nervous system, culminating in EEG spikes and tonic-clonic convulsions. GABA enhancers and sodium channel antagonists improve seizure latencies in HBO<sub>2</sub> when administered individually, while combining antiepileptic drugs from different functional classes can provide greater seizure latency. We examined the combined effectiveness of GABA enhancers (tiagabine and gabapentin) with sodium channel antagonists (carbamazepine and lamotrigine) in delaying HBO<sub>2</sub>-induced seizures. A series of experiments in C57BL/6 mice exposed to 100% oxygen at 5 atmospheres absolute (ATA) were performed. We predicted equally effective doses from individual drug-dose response curves, and the combinations of tiagabine + carbamazepine or lamotrigine were tested to determine the maximally effective combined doses to be used in subsequent experiments designed to identify the type of pharmacodynamic interaction for three fixed-ratio combinations (1:3, 1:1, and 3:1) using isobolographic analysis. For both combinations, the maximally effective combined doses increased seizure latency over controls &gt;\xe2\x80\x895-fold and were determined to interact synergistically for fixed ratios 1:1 and 3:1, additive for 1:3. These results led us to explore whether the benefits of these drug combinations could be extended to the lungs, since a centrally mediated mechanism is believed to mediate hyperoxic-induced cardiogenic lung injury. Indeed, both combinations attenuated bronchoalveolar lavage protein content by ~\xe2\x80\x8950%. Combining tiagabine with carbamazepine or lamotrigine not only affords greater antiseizure protection in HBO<sub>2</sub> but also allows for lower doses to be used, minimizing side effects, and attenuating acute lung injury.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Demchenko</LastName>\n                    <ForeName>Ivan T</ForeName>\n                    <Initials>IT</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Center for Hyperbaric Medicine and Environmental Physiology, Duke University Medical Center, Durham, NC, USA.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhilyaev</LastName>\n                    <ForeName>Sergei Yu</ForeName>\n                    <Initials>SY</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Alekseeva</LastName>\n                    <ForeName>Olga S</ForeName>\n                    <Initials>OS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Krivchenko</LastName>\n                    <ForeName>Alexander I</ForeName>\n                    <Initials>AI</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Piantadosi</LastName>\n                    <ForeName>Claude A</ForeName>\n                    <Initials>CA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Center for Hyperbaric Medicine and Environmental Physiology, Duke University Medical Center, Durham, NC, USA.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Duke University Medical Center, Durham, NC, USA.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gasier</LastName>\n                    <ForeName>Heath G</ForeName>\n                    <Initials>HG</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5895-4542</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Military and Emergency Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. heath.gasier@usuhs.edu.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>N00014-15-1-2072</GrantID>\n                    <Agency>Office of Naval Research</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>0132-2018-0011</GrantID>\n                    <Agency>Russian Academy of Sciences (RU)</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>30</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Neurotox Res</MedlineTA>\n            <NlmUniqueID>100929017</NlmUniqueID>\n            <ISSNLinking>1029-8428</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000927">Anticonvulsants</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D026941">Sodium Channel Blockers</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>33CM23913M</RegistryNumber>\n                <NameOfSubstance UI="D002220">Carbamazepine</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>6CW7F3G59X</RegistryNumber>\n                <NameOfSubstance UI="D000077206">Gabapentin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>S88TT14065</RegistryNumber>\n                <NameOfSubstance UI="D010100">Oxygen</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>U3H27498KS</RegistryNumber>\n                <NameOfSubstance UI="D000077213">Lamotrigine</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>Z80I64HMNP</RegistryNumber>\n                <NameOfSubstance UI="D000078308">Tiagabine</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000927" MajorTopicYN="N">Anticonvulsants</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002220" MajorTopicYN="N">Carbamazepine</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000077206" MajorTopicYN="N">Gabapentin</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006931" MajorTopicYN="Y">Hyperbaric Oxygenation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000077213" MajorTopicYN="N">Lamotrigine</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName>\n                <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012640" MajorTopicYN="N">Seizures</DescriptorName>\n                <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D026941" MajorTopicYN="N">Sodium Channel Blockers</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000078308" MajorTopicYN="N">Tiagabine</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Antiepileptic drugs</Keyword>\n            <Keyword MajorTopicYN="N">CNS oxygen toxicity</Keyword>\n            <Keyword MajorTopicYN="N">Drug synergy</Keyword>\n            <Keyword MajorTopicYN="N">Isobolographic analysis</Keyword>\n            <Keyword MajorTopicYN="N">Neuroprotection</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>06</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>09</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>24</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>5</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>6</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31148118</ArticleId>\n            <ArticleId IdType="doi">10.1007/s12640-019-00063-5</ArticleId>\n            <ArticleId IdType="pii">10.1007/s12640-019-00063-5</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Electroencephalogr Clin Neurophysiol. 1967 Mar;22(3):231-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">4163821</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epilepsy Res. 1991 Mar;8(2):117-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2065642</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Syst Biol. 2007;3:80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17332758</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Can J Biochem Physiol. 1963 Sep;41:1907-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14069574</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Appl Physiol (1985). 2012 Jun;112(11):1814-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22442027</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharmacol Exp Ther. 1949 Jun;96(2):99-113</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18152921</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Exp Immunol. 1977 Apr;28(1):1-18</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">324671</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurochem. 1969 Mar;16(3):281-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">5795581</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Aviat Med. 1950 Oct;21(5):401-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14778793</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Electroencephalogr Clin Neurophysiol. 1969 Aug;27(2):219</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">4184194</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epilepsy Res. 1992 Nov;13(2):107-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1334455</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurologist. 2011 Jan;17(1):31-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21192190</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharmacol. 2014 Oct 15;741:237-46</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25149665</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Pharm Assoc Am Pharm Assoc. 1957 Mar;46(3):208-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">13502156</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epilepsia. 1995 Jun;36(6):612-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7555976</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epilepsia. 2000 Nov;41(11):1364-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11077449</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Neuropharmacol. 1964 May;3:279-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14336537</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epilepsia. 2002 Sep;43(9):956-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12199720</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Electroencephalogr Clin Neurophysiol. 1953 Nov;5(4):521-4</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">13107598</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Appl Physiol (1985). 2018 Jul 19;:</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30024340</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacol Biochem Behav. 2003 May;75(2):319-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12873622</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharmacol. 1990 Apr 25;179(3):463-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2364995</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Appl Physiol (1985). 2013 Sep;115(6):861-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23722711</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epilepsia. 1997 Sep;38(9):959-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9579933</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharmacol Exp Ther. 2001 Sep;298(3):865-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11504778</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharmacol. 2005 Jun 15;516(3):212-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15958264</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Appl Physiol (1985). 2014 Sep 1;117(5):525-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24994889</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Pharmacol. 1991 Sep 17;202(2):171-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1802744</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L229-38</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17416738</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurochem. 1967 Nov;14(11):1067-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">6058524</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Can J Physiol Pharmacol. 1965 May;43:405-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14324243</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacol Res Perspect. 2015 Jun;3(3):e00149</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26171228</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Child Neurol. 1997 Nov;12 Suppl 1:S2-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9429123</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Pharmacol. 2014 Feb;85(2):381-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24319110</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>P T. 2010 Jul;35(7):392-415</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20689626</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharmacol Exp Ther. 2012 Jul;342(1):2-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22511201</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Emerg Med. 1983 Jan;12(1):38-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">6849525</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Epilepsy Res. 2002 Nov;52(1):15-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12445956</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurosci Lett. 2017 Jul 13;653:283-287</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28579483</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Physiol Lung Cell Mol Physiol. 2011 Jan;300(1):L102-11</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20971806</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Brain Res. 2017 Feb 15;1657:347-354</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28057450</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'